Location History:
- Tokyo, JP (2006 - 2011)
- Osaka, JP (2018)
Company Filing History:
2 out of 257 
1 out of 73 Years Active: 2006-2018
Title: Hidemitsu Higashi: Innovator in Ophthalmic Therapeutics
Introduction
Hidemitsu Higashi is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of ophthalmology, particularly in developing therapeutic agents for ocular diseases. With a total of 3 patents to his name, Higashi's work reflects a commitment to advancing medical science.
Latest Patents
Higashi's latest patents include a therapeutic agent for ophthalmic diseases caused by ocular angiogenesis. This invention features a morpholine compound that serves as an active ingredient, which can be utilized in treating or preventing various ophthalmic conditions. The compound is characterized by specific structural formulas that enhance its efficacy in targeting ocular diseases. Additionally, he has developed a morpholine compound that shows promise in treating immune or inflammatory diseases, demonstrating its versatility in pharmaceutical applications.
Career Highlights
Throughout his career, Hidemitsu Higashi has worked with prominent companies such as Mitsubishi Tanabe Pharma Corporation and Mitsubishi Pharma Corporation. His experience in these organizations has allowed him to collaborate with leading experts in the pharmaceutical industry, further enhancing his innovative capabilities.
Collaborations
Higashi has collaborated with notable colleagues, including Yoshihito Tanaka and Masatoshi Kiuchi. These partnerships have contributed to the development of his patents and have fostered a collaborative environment for innovation in the field of ophthalmology.
Conclusion
Hidemitsu Higashi's contributions to ophthalmic therapeutics highlight his role as a significant inventor in the medical field. His innovative work continues to pave the way for advancements in the treatment of ocular diseases.